Market Overview:
The global controlled substances market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for prescription drugs. In addition, the increasing use of opioids for pain management is also contributing to the growth of this market. On the basis of type, opioids accounted for the largest share in 2017 and are expected to maintain its dominance during the forecast period. This can be attributed to their high efficacy in pain management and their wide usage across various applications such as hospital pharmacies, retail pharmacies, and online pharmacies.
Product Definition:
A controlled substance is a drug or other substance that is regulated by the government because it has the potential for abuse. Controlled substances are placed in one of five categories, or schedules, based on their potential for abuse and medicinal value. The importance of controlled substances lies in their ability to be abused and to cause addiction.
Opioids:
Opioids are natural substances found in the latex of the Opium Poppy plant. Opioids are mainly used for treating pain and as anesthetic agents. The most commonly known opioids include codeine, morphine, and oxycodone. Other opioids include hydrocodone, fentanyl, and propoxyphene; however these drugs have been removed from the market due to their high abuse rate coupled with severe side effects caused by long-term use such as tolerance & dependency.
Stimulants:
Stimulants are drugs that increase the activity of the central nervous system. Stimulants can either be natural or synthetic in nature. Some of the most commonly used stimulants are caffeine, nicotine, epinephrine (adrenaline), and amphetamine among others. Caffeine is by far one of the most widely consumed stimulant across the globe on a daily basis as it is found naturally in coffee and tea leaves as well as some cocoa plants.
Application Insights:
Based on application, the global controlled substances market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacy segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as high usage rates of opioids and other depressants across hospitals globally. Furthermore, online distribution channels have played a major role in reducing the availability of controlled substances at retail stores which has further reduced their consumption at home by patients who are supposed to receive them for medical purposes only.
The growing use of marijuana for recreational and medicinal purposes has been a major driver behind its legalization or decriminalization in several countries worldwide including Canada, Australia and New Zealand among others.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to factors such as high per capita income, improved healthcare infrastructure and availability of effective treatment facilities. Moreover, increasing prevalence of substance use disorders coupled with rising awareness about mental health issues is also projected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years due to various socio-economic factors such as growing population and demand for controlled substances for medical purposes driving their consumption especially in countries like India and China. Furthermore, economic development along with improvement in healthcare infrastructure will also boost regional product demand over the next eight years or so.
Growth Factors:
- Increasing demand for pain relief medication: The global controlled substances market is expected to grow at a CAGR of 5.5% from 2016 to 2021, owing to the increasing demand for pain relief medication. This is mainly due to the growing geriatric population and rising prevalence of chronic diseases such as cancer, arthritis, and diabetes.
- Rising use of opioids in palliative care: Opioids are increasingly being used in palliative care for relieving severe pain in patients nearing the end of their lives. This is expected to drive the growth of the global controlled substances market during the forecast period.
- Growing illicit trade of drugs: The illicit trade of drugs is a major challenge faced by governments across the world and it has been identified as one of the key drivers for growth in this market during 2016-2021 period .This can be attributed to high profits associated with drug trafficking and lackadaisical enforcement measures by law enforcement agencies worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Controlled Substances Market Research Report
By Type
Opioids, Stimulants, Depressants, Marijuana, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Johnson & Johnson, Pfizer, Siegfried AG, GlaxoSmithKline, Teva Pharmaceuticals, Mylan, Takeda Pharmaceutical, Sun Pharmaceutical, Daiichi Sankyo, Akorn Inc, Tilray, Medical Marijuana, Inc, Consort Medical, Purdue Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Controlled Substances Market Report Segments:
The global Controlled Substances market is segmented on the basis of:
Types
Opioids, Stimulants, Depressants, Marijuana, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Pfizer
- Siegfried AG
- GlaxoSmithKline
- Teva Pharmaceuticals
- Mylan
- Takeda Pharmaceutical
- Sun Pharmaceutical
- Daiichi Sankyo
- Akorn Inc
- Tilray
- Medical Marijuana, Inc
- Consort Medical
- Purdue Pharma
Highlights of The Controlled Substances Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Opioids
- Stimulants
- Depressants
- Marijuana
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Controlled Substances Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Controlled substances are drugs and other chemicals that have been classified by the U.S. Drug Enforcement Administration (DEA) as having a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Controlled substances include both legal and illegal drugs.
Some of the key players operating in the controlled substances market are Johnson & Johnson, Pfizer, Siegfried AG, GlaxoSmithKline, Teva Pharmaceuticals, Mylan, Takeda Pharmaceutical, Sun Pharmaceutical, Daiichi Sankyo, Akorn Inc, Tilray, Medical Marijuana, Inc, Consort Medical, Purdue Pharma.
The controlled substances market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Controlled Substances Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Controlled Substances Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Controlled Substances Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Controlled Substances Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Controlled Substances Market Size & Forecast, 2018-2028
4.5.1 Controlled Substances Market Size and Y-o-Y Growth
4.5.2 Controlled Substances Market Absolute $ Opportunity
Chapter 5 Global Controlled Substances Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Controlled Substances Market Size Forecast by Type
5.2.1 Opioids
5.2.2 Stimulants
5.2.3 Depressants
5.2.4 Marijuana
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Controlled Substances Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Controlled Substances Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Controlled Substances Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Controlled Substances Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Controlled Substances Analysis and Forecast
9.1 Introduction
9.2 North America Controlled Substances Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Controlled Substances Market Size Forecast by Type
9.6.1 Opioids
9.6.2 Stimulants
9.6.3 Depressants
9.6.4 Marijuana
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Controlled Substances Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Controlled Substances Analysis and Forecast
10.1 Introduction
10.2 Europe Controlled Substances Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Controlled Substances Market Size Forecast by Type
10.6.1 Opioids
10.6.2 Stimulants
10.6.3 Depressants
10.6.4 Marijuana
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Controlled Substances Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Controlled Substances Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Controlled Substances Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Controlled Substances Market Size Forecast by Type
11.6.1 Opioids
11.6.2 Stimulants
11.6.3 Depressants
11.6.4 Marijuana
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Controlled Substances Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Controlled Substances Analysis and Forecast
12.1 Introduction
12.2 Latin America Controlled Substances Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Controlled Substances Market Size Forecast by Type
12.6.1 Opioids
12.6.2 Stimulants
12.6.3 Depressants
12.6.4 Marijuana
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Controlled Substances Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Controlled Substances Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Controlled Substances Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Controlled Substances Market Size Forecast by Type
13.6.1 Opioids
13.6.2 Stimulants
13.6.3 Depressants
13.6.4 Marijuana
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Controlled Substances Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Controlled Substances Market: Competitive Dashboard
14.2 Global Controlled Substances Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Pfizer
14.3.3 Siegfried AG
14.3.4 GlaxoSmithKline
14.3.5 Teva Pharmaceuticals
14.3.6 Mylan
14.3.7 Takeda Pharmaceutical
14.3.8 Sun Pharmaceutical
14.3.9 Daiichi Sankyo
14.3.10 Akorn Inc
14.3.11 Tilray
14.3.12 Medical Marijuana, Inc
14.3.13 Consort Medical
14.3.14 Purdue Pharma
